Chapter Diagnostics develops multiplex NGS assays for sexually transmitted infections (chlamydia, gonorrhea and etc), NGS COVID-19, NGS HPV and NGS cancer gene panels.
| Website | http://www.chapterdx.com |
| Revenue | $2 million |
| Employees | 4 (4 on RocketReach) |
| Address | 1455 Adams Dr Ste 2162, Menlo Park, California 94025, US |
| Industry | Business Services General, Business Services |
| Competitors | Thermo Fisher Scientific, Natera, Exact Sciences, Guardant Health, GRAIL, Foundation Medicine, NeoGenomics Laboratories, Invitae, Biocept, Inc., carisls +38 more (view full list) |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 541713 Companies |
Looking for a particular Chapter Diagnostics employee's phone or email?
The Chapter Diagnostics annual revenue was $2 million in 2026.
Baback Gharizadeh is the Co-Founder and Chief Scientific Officer of Chapter Diagnostics.
4 people are employed at Chapter Diagnostics.
Chapter Diagnostics is based in Menlo Park, California.
The NAICS codes for Chapter Diagnostics are [541, 5417, 54, 54171, 541713].
The SIC codes for Chapter Diagnostics are [87, 873].